Literature DB >> 26948025

Engrailed-2 might play an anti-oncogenic role in clear-cell renal cell carcinoma.

Cai-Yong Lai1,2, Yin Xu1, Gan-Shen Yu1, Xun Wu1, Yun-Fei Li1, Bin Pan1, Bao-Li Heng1, Yi-Jun Xue2, Ze-Xuan Su3.   

Abstract

Our preliminary study indicated that Engrailed-2 (EN2) is downregulated but also ectopically expressed in clear-cell renal cell carcinoma (CCRCC), and the absence of EN2 expression was associated with poor histological grade. However, the specific roles of EN2 in CCRCC have yet to be elucidated. In the present study, we examined the effects of inhibiting EN2 expression by human renal tubular epithelial cells (HK-2) and overexpressing EN2 by human clear-cell renal cells (786-O). Results showed that EN2 inhibition accelerated HK-2 cell proliferation, shortened the cell cycle, reduced apoptosis, and acted more invasively. By contrast, EN2 overexpression in 786-O cells decelerated the proliferative ability of 786-O, increased the percentage of cell apoptosis, and weakened the invasive ability. Overall, the results demonstrated that EN2 might play an anti-oncogenic role in oncogenesis and development of CCRCC, thereby maintaining the normal growth of human renal tubular epithelial cells.

Entities:  

Keywords:  Anti-oncogene; Clear-cell renal cell carcinoma; Engrailed-2

Mesh:

Substances:

Year:  2016        PMID: 26948025     DOI: 10.1007/s10735-016-9665-4

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  22 in total

1.  Identification of a signal sequence necessary for the unconventional secretion of Engrailed homeoprotein.

Authors:  A Joliot; A Maizel; D Rosenberg; A Trembleau; S Dupas; M Volovitch; A Prochiantz
Journal:  Curr Biol       Date:  1998-07-16       Impact factor: 10.834

2.  Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker.

Authors:  Richard Morgan; Richard T Bryan; Saqib Javed; Francesca Launchbury; Maurice P Zeegers; K K Cheng; Nicholas D James; D Michael A Wallace; Carolyn D Hurst; Douglas G Ward; Margaret A Knowles; Hardev Pandha
Journal:  Eur J Cancer       Date:  2013-02-21       Impact factor: 9.162

3.  HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition.

Authors:  Xinyan Wu; Hexin Chen; Belinda Parker; Ethel Rubin; Tao Zhu; Ji Shin Lee; Pedram Argani; Saraswati Sukumar
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

4.  Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer.

Authors:  Richard Morgan; Angela Boxall; Aagna Bhatt; Michael Bailey; Richard Hindley; Stephen Langley; Hayley C Whitaker; David E Neal; Mohammed Ismail; Hamish Whitaker; Nicola Annels; Agnieszka Michael; Hardev Pandha
Journal:  Clin Cancer Res       Date:  2011-03-01       Impact factor: 12.531

5.  The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.

Authors:  Zuncai Wang; Sonika Dahiya; Heather Provencher; Beth Muir; Erin Carney; Kathryn Coser; Toshi Shioda; Xiao-Jun Ma; Dennis C Sgroi
Journal:  Clin Cancer Res       Date:  2007-11-01       Impact factor: 12.531

Review 6.  EN2 in Prostate Cancer.

Authors:  Sophie E McGrath; Agnieszka Michael; Richard Morgan; Hardev Pandha
Journal:  Adv Clin Chem       Date:  2015-07-21       Impact factor: 5.394

7.  Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.

Authors:  Yali Zhai; Rork Kuick; Bin Nan; Ichiro Ota; Stephen J Weiss; Cornelia L Trimble; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

8.  Upregulation of centromere protein H is associated with progression of renal cell carcinoma.

Authors:  Xun Wu; Youcheng Lin; Liping Shi; Yi Huang; Caiyong Lai; Yongqiang Wang; Meng Zhang; Shupeng Wang; Baoli Heng; Ganshen Yu; Xinghua Du; Lu Fang; Yu Fu; Jie Chen; Zexiong Guo; Zexuan Su; Song Wu
Journal:  J Mol Histol       Date:  2015-08-07       Impact factor: 2.611

9.  Prognostic prediction and diagnostic role of intercellular adhesion molecule-1 (ICAM1) expression in clear cell renal cell carcinoma.

Authors:  Xuebing Shi; Jifa Jiang; Xiaobing Ye; Yanyan Liu; Qiong Wu; Lu Wang
Journal:  J Mol Histol       Date:  2014-02-18       Impact factor: 2.611

10.  Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.

Authors:  Hardev Pandha; Karen D Sorensen; Thorsten F Orntoft; Stephen Langley; Soren Hoyer; Michael Borre; Richard Morgan
Journal:  BJU Int       Date:  2012-05-15       Impact factor: 5.588

View more
  5 in total

1.  Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma.

Authors:  Meng Zhang; Wei Lu; Yiqiang Huang; Jizhou Shi; Xun Wu; Xiaolong Zhang; Runze Jiang; Zhiming Cai; Song Wu
Journal:  J Mol Histol       Date:  2016-06-20       Impact factor: 2.611

2.  Engrailed-2 promoter hyper-methylation is associated with its downregulation in clear cell renal cell carcinoma.

Authors:  Cai-Yong Lai; Gan-Shen Yu; Yin Xu; Xun Wu; Bao-Li Heng; Yi-Jun Xue; Ze-Xuan Su
Journal:  Oncol Lett       Date:  2017-09-19       Impact factor: 2.967

3.  microRNA-27b inhibits cell proliferation and invasion in bladder cancer by targeting engrailed-2.

Authors:  Yunfei Li; Qilin Duan; Lu Gan; Wei Li; Jianggen Yang; Guixiao Huang
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

4.  Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate Cancer predict prostatic disease progression.

Authors:  Qi Li; Yibo Shi; Rigai Sa; Jun Hao; Jinhao Hu; Mulun Xiao; Chaoliang Wang; Liang Yan; Baoping Qiao; Guoxun Chen
Journal:  BMC Cancer       Date:  2020-06-15       Impact factor: 4.430

5.  Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide.

Authors:  Tengfei Li; Wanchun Yang; Mao Li; Shuxin Zhang; Xingwang Zhou; Mingrong Zuo; Qiuyun Yuan; Mina Chen; Yanhui Liu
Journal:  Cancer Cell Int       Date:  2020-03-02       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.